BIOMAT Database Logo BIOMAT Database Logo

[Products of degradation of fibrinogen and their importance in hemostasis]. 1965

E Kowalski, and M Kopeć

UI MeSH Term Description Entries
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Kowalski, and M Kopeć
Fibrinogen and fibrin degradation products: their differentiation.
December 1975, Thrombosis et diathesis haemorrhagica,
E Kowalski, and M Kopeć
[Diagnostic importance of fibrinogen degradation products in viral hepatitis].
August 1978, Klinicheskaia meditsina,
E Kowalski, and M Kopeć
[FIBRINOGEN CLEAVAGE PRODUCTS AND HEMOSTASIS].
March 1965, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
E Kowalski, and M Kopeć
[Fibrinogen and fibrin split products and their biological importance].
January 1971, Folia haematologica (Leipzig, Germany : 1928),
E Kowalski, and M Kopeć
The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
January 1967, Transactions of the Association of American Physicians,
E Kowalski, and M Kopeć
Fibrinogen degradation products.
June 1971, The New England journal of medicine,
E Kowalski, and M Kopeć
[Fibrinogen degradation products].
January 1998, Nihon rinsho. Japanese journal of clinical medicine,
E Kowalski, and M Kopeć
Fibrinogen, fibrinogen degradation products and erythrocyte flexibility.
October 1977, Thrombosis and haemostasis,
E Kowalski, and M Kopeć
[Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
December 1993, Rinsho byori. The Japanese journal of clinical pathology,
E Kowalski, and M Kopeć
[Fibrin and fibrinogen degradation products].
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!